Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Cencora raised its 2025 earnings forecast after a strong Q2 driven by U.S. drug sales, though total revenue of $75.5 billion slightly missed expectations.
Healthcare distributor Cencora (NYSE:COR) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 10.3% year on year to $75.45 billion. Its non-GAAP profit of $4.42 per share was 7.9% above analysts’ consensus estimates.
The biggest companies in the world call the S&P 500 (^GSPC) home, but only a handful are still growing rapidly.
Some of these industry leaders are executing exceptionally well and rewarding shareholders.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top S&P500 gainers and losers in today's session.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session.
Despite a broad market correction in 2025, three S&P 500 stocks have defied the downturn, delivering standout performance and showcasing strong fundamentals.
Since April 2020, the S&P 500 has delivered a total return of 101%. But one standout stock has more than doubled the market - over the past five years, Cencora has surged 231% to $285.36 per share. Its momentum hasn’t stopped as it’s also gained 29.7% in the last six months thanks to its solid quarterly results, beating the S&P by 36.7%.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Alignment Healthcare (NASDAQ:ALHC) and the rest of the health insurance providers stocks fared in Q4.
An ETF portfolio manager highlights how his fund is beating the broader market and what advice he has for investors in 2025 in an exclusive Benzinga interview.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including CVS Health (NYSE:CVS) and its peers.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Cencora (NYSE:COR) and its peers.
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital,
and those that can maintain this trifecta year in and year out often become the legends of the investing world.
Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q4 health insurance providers earnings season.
